These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15848821)

  • 1. The self-perceived role and educational needs of pharmaceutical representatives: a survey.
    O'Donnell MJ; Molloy DW; Smith SD; Dubois S; Russo RM
    Educ Health (Abingdon); 2004 Nov; 17(3):339-45. PubMed ID: 15848821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National survey on the attitudes of Canadian physicians towards drug-detailing by pharmaceutical representatives.
    Strang D; Gagnon M; Molloy W; Bedard M; Darzins P; Etchells E; Davidson W
    Ann R Coll Physicians Surg Can; 1996 Dec; 29(8):474-8. PubMed ID: 12380577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
    Edwards D; Ballantyne A
    Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric resident and faculty views on and interactions with the pharmaceutical industry.
    Misra S; Ganzini L; Keepers G
    Acad Psychiatry; 2010; 34(2):102-8. PubMed ID: 20224017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical student views on interactions with pharmaceutical representatives.
    Ganzini L; Chen Z; Peters D; Misra S; Macht M; Osborne M; Keepers G
    Acad Psychiatry; 2012 May; 36(3):183-7. PubMed ID: 22751818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes and behaviors of psychiatry residents toward pharmaceutical representatives before and after an educational intervention.
    Randall ML; Rosenbaum JR; Rohrbaugh RM; Rosenheck RA
    Acad Psychiatry; 2005; 29(1):33-9. PubMed ID: 15772402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric training program engagement with the pharmaceutical industry: an educational issue, not strictly an ethical one.
    Mohl PC
    Acad Psychiatry; 2005; 29(2):215-21. PubMed ID: 15937270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A national survey on the effect of pharmaceutical promotion on medical students.
    Vainiomäki M; Helve O; Vuorenkoski L
    Med Teach; 2004 Nov; 26(7):630-4. PubMed ID: 15763854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes of preclinical and clinical medical students toward interactions with the pharmaceutical industry.
    Hyman PL; Hochman ME; Shaw JG; Steinman MA
    Acad Med; 2007 Jan; 82(1):94-9. PubMed ID: 17198299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Industry support of graduate medical education in surgery.
    Nakayama DK; Bozeman AP
    Am Surg; 2009 May; 75(5):395-400. PubMed ID: 19445290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Academic administrators' attitudes towards interprofessional education in Canadian schools of health professional education.
    Curran VR; Deacon DR; Fleet L
    J Interprof Care; 2005 May; 19 Suppl 1():76-86. PubMed ID: 16096147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention.
    Schneider JA; Arora V; Kasza K; Van Harrison R; Humphrey H
    Acad Med; 2006 Jul; 81(7):595-602. PubMed ID: 16799279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To what extent do educational interventions impact medical trainees' attitudes and behaviors regarding industry-trainee and industry-physician relationships?
    Carroll AE; Vreeman RC; Buddenbaum J; Inui TS
    Pediatrics; 2007 Dec; 120(6):e1528-35. PubMed ID: 18055668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with physicians' reliance on pharmaceutical sales representatives.
    Anderson BL; Silverman GK; Loewenstein GF; Zinberg S; Schulkin J
    Acad Med; 2009 Aug; 84(8):994-1002. PubMed ID: 19638762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generics market in Greece: the pharmaceutical industry's beliefs.
    Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
    Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The attitude of physicians regarding the promotion strategies of the pharmaceutical industry].
    Castresana L; Mejia R; Aznar M
    Medicina (B Aires); 2005; 65(3):247-51. PubMed ID: 16042137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of legislative changes in drug promotion on medical students: questionnaire survey.
    Vuorenkoski L; Valta M; Helve O
    Med Educ; 2008 Dec; 42(12):1172-7. PubMed ID: 19120947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dangerous liaisons--physicians and pharmaceutical sales representatives].
    Granja M
    Acta Med Port; 2005; 18(1):61-8. PubMed ID: 16202335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.